25 May 2023 - AGM statement
The AIM-listed international consumer healthcare company has issued a trading statement to coincide with its AGM which has revealed that sales in the first four months of 2023 are ahead of the same period in 2022. However, adverse currency movements, particularly the strengthening of sterling against the US dollar and higher interest rates may mean that adjusted pre-tax profits for the year may be slightly lower than expected. Previous expectations were for adjusted pre-tax profits of £37m for 2023 for earnings per share of 5.3p - if these now come in at . . .
This content is restricted to members only. We offer three packages from 1 month to a whole year of daily tips, market news and commentary, plus our monthly newsletters.
Registration is quick and simple HERE.
Already a member, log in HERE.
